comparemela.com

Latest Breaking News On - Gemini digital twin - Page 1 : comparemela.com

GNS Announces Abstract and Oral Poster Presentation at CTAD & ASH, 2022 Annual Conferences

/PRNewswire/ GNS, the leader in the application of Causal AI and simulation and "Digital Twins" to discover new drugs, today announced two abstracts and two.

United statesSan franciscoDerek walkamaApoorva bharthurZena sfeirTodd oaklandShokeen deepanshiJeanne latourelleDaniel vagieLaurel mayhewAmerican society of hematologyBruce churchGemini digital twinMultiple myelomaClinical trialsAmerican society

GNS Announces Abstract and Oral Poster Presentation at CTAD & ASH, 2022 Annual Conferences

SOMERVILLE, Mass., Nov. 23, 2022 /PRNewswire/ GNS, the leader in the application of Causal AI and simulation and Digital Twins to discover ne.

United statesSan franciscoDerek walkamaApoorva bharthurZena sfeirTodd oaklandShokeen deepanshiJeanne latourelleDaniel vagieLaurel mayhewAmerican society of hematologyBruce churchGemini digital twinMultiple myelomaClinical trialsAmerican society

GNS Appoints John Maraganore as Chair of the Board

/PRNewswire/ GNS, the leader in the application of Causal AI and simulation and "Digital Twins" to discover new drugs, today announced that John Maraganore,.

Timothy thompsonZena sfeirColin hillJohn maraganoreBiogen to millennium pharmaceuticals alnylamProkidney corpLorem foundation advisory councilAlnylam pharmaceuticalsTakeda pharmaceuticalsUniversity of chicagoBoard of the biotechnology innovation organizationUpjohn companyZymogenetics incAgios pharmaceuticalsBusiness development at biogen incMillennium pharmaceuticals inc

GNS and Servier Announce AI Collaboration to Advance Multiple Myeloma Drug Discovery and Clinical Development

/PRNewswire/ GNS, the leader in the use of "Digital Twins" and Causal AI & biosimulation technology for biopharmaceutical drug discovery and development,.

France generalZena sfeirClaude bertrandJoe donahueSonia marquesJulia ferreiraServier group franceMyeloma research foundationServier groupMultiple myelomaDigital twinGemini digital twinChief business officerMultiple myeloma research foundation

GNS and Servier Announce AI Collaboration to Advance Multiple Myeloma Drug Discovery and Clinical Development

SOMERVILLE, Mass. and PARIS, Aug. 24, 2022 /PRNewswire/ GNS, the leader in the use of Digital Twins and Causal AI & biosimulation technology .

France generalZena sfeirClaude bertrandJoe donahueSonia marquesJulia ferreiraGroup franceMyeloma research foundationServier groupMultiple myelomaGemini digital twinDigital twinChief business officerMultiple myeloma research foundationAbout servierTwittermedia contacts

vimarsana © 2020. All Rights Reserved.